• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Topical 5-fluorouracil application in management of odontogenic keratocysts.局部应用5-氟尿嘧啶治疗牙源性角化囊肿
J Oral Biol Craniofac Res. 2020 Oct-Dec;10(4):404-406. doi: 10.1016/j.jobcr.2020.07.008. Epub 2020 Jul 22.
2
The Role of 5-Fluorouracil in Preventing Recurrence After Enucleation of Odontogenic Keratocyst: A Case Report.5-氟尿嘧啶在预防牙源性角化囊肿摘除术后复发中的作用:一例报告
Cureus. 2023 Sep 6;15(9):e44777. doi: 10.7759/cureus.44777. eCollection 2023 Sep.
3
Comparison of the effectiveness of 5-Fluorouracil and modified Carnoy's solution in reducing the recurrence of odontogenic keratocyst.5-氟尿嘧啶与改良卡诺伊溶液在降低牙源性角化囊肿复发率方面的有效性比较
J Oral Biol Craniofac Res. 2023 May-Jun;13(3):436-441. doi: 10.1016/j.jobcr.2023.03.007. Epub 2023 May 8.
4
Effectiveness of different treatments for odontogenic keratocyst: a network meta-analysis.不同治疗方法治疗牙源性角化囊肿的疗效:网络荟萃分析。
Int J Oral Maxillofac Surg. 2023 Jan;52(1):32-43. doi: 10.1016/j.ijom.2022.09.004. Epub 2022 Sep 21.
5
Comparing 5-Fluorouracil Versus Modified Carnoy's Solution for the Treatment of Odontogenic Keratocysts: A Systematic Review and Meta-Analysis.比较 5-氟尿嘧啶与改良 Carnoy 液治疗牙源性角化囊肿的疗效:系统评价和荟萃分析。
J Oral Maxillofac Surg. 2024 Nov;82(11):1433-1440. doi: 10.1016/j.joms.2024.06.181. Epub 2024 Jul 5.
6
An evidence-based surgical algorithm for management of odontogenic keratocyst.基于证据的牙源性角化囊肿外科治疗算法。
Oral Maxillofac Surg. 2023 Jun;27(2):201-212. doi: 10.1007/s10006-022-01064-z. Epub 2022 Apr 27.
7
Antimetabolite in the Management of Odontogenic Keratocyst-A Case Report.抗代谢药物在牙源性角化囊肿治疗中的应用——病例报告
J Maxillofac Oral Surg. 2023 Mar;22(1):132-135. doi: 10.1007/s12663-022-01751-0. Epub 2022 Jul 13.
8
Conservative Management of Odontogenic Keratocyst in a Tertiary Hospital.三级医院牙源性角化囊肿的保守治疗
Ann Maxillofac Surg. 2020 Jan-Jun;10(1):122-126. doi: 10.4103/ams.ams_260_18. Epub 2020 Jun 8.
9
Odontogenic keratocyst: to decompress or not to decompress? A comparative study of decompression and enucleation versus resection/peripheral ostectomy.牙源性角化囊肿:减压还是不减压?减压与摘除术及切除/周边骨切除术的对比研究
J Oral Maxillofac Surg. 2007 Apr;65(4):640-4. doi: 10.1016/j.joms.2006.06.284.
10
How effective is 5-Fluorouracil as an adjuvant in the management of odontogenic keratocyst? A systematic review and meta-analysis.5-氟尿嘧啶作为牙源性角化囊肿辅助治疗的效果如何?系统评价和荟萃分析。
Br J Oral Maxillofac Surg. 2022 Jul;60(6):746-754. doi: 10.1016/j.bjoms.2022.02.001. Epub 2022 Feb 17.

引用本文的文献

1
Targeting the Odontogenic Keratocysts: Therapeutic Potential of 5-Fluorouracil Through Thymidylate Synthase Inhibition.靶向牙源性角化囊肿:5-氟尿嘧啶通过抑制胸苷酸合成酶的治疗潜力。
Cureus. 2025 Apr 24;17(4):e82905. doi: 10.7759/cureus.82905. eCollection 2025 Apr.
2
The Role of 5-Fluorouracil in Preventing Recurrence After Enucleation of Odontogenic Keratocyst: A Case Report.5-氟尿嘧啶在预防牙源性角化囊肿摘除术后复发中的作用:一例报告
Cureus. 2023 Sep 6;15(9):e44777. doi: 10.7759/cureus.44777. eCollection 2023 Sep.
3
Comparison of the effectiveness of 5-Fluorouracil and modified Carnoy's solution in reducing the recurrence of odontogenic keratocyst.5-氟尿嘧啶与改良卡诺伊溶液在降低牙源性角化囊肿复发率方面的有效性比较
J Oral Biol Craniofac Res. 2023 May-Jun;13(3):436-441. doi: 10.1016/j.jobcr.2023.03.007. Epub 2023 May 8.
4
Combined conservative treatment of a recurrent mandibular keratocyst by enucleation, diode laser, 5-Fluorouracil and dental implants: a case report with 18 years-follow up.通过摘除术、二极管激光、5-氟尿嘧啶和牙种植体联合保守治疗复发性下颌角化囊肿:一例18年随访的病例报告
Med Pharm Rep. 2023 Jan;96(1):106-110. doi: 10.15386/mpr-2067. Epub 2023 Jan 25.
5
Antimetabolite in the Management of Odontogenic Keratocyst-A Case Report.抗代谢药物在牙源性角化囊肿治疗中的应用——病例报告
J Maxillofac Oral Surg. 2023 Mar;22(1):132-135. doi: 10.1007/s12663-022-01751-0. Epub 2022 Jul 13.
6
5-fluorouacil in the treatment of odontogenic keratocysts-incidence of recurrence and inferior alveolar nerve paresthesia: a systematic review.5-氟尿嘧啶治疗牙源性角化囊肿——复发率和下牙槽神经感觉异常:系统评价。
Oral Maxillofac Surg. 2023 Sep;27(3):489-496. doi: 10.1007/s10006-022-01090-x. Epub 2022 Jun 18.

本文引用的文献

1
New tumour entities in the 4th edition of the World Health Organization Classification of Head and Neck tumours: odontogenic and maxillofacial bone tumours.世界卫生组织头颈部肿瘤分类第4版中的新肿瘤实体:牙源性和颌面骨肿瘤。
Virchows Arch. 2018 Mar;472(3):331-339. doi: 10.1007/s00428-017-2182-3. Epub 2017 Jul 3.
2
What surgical treatment has the lowest recurrence rate following the management of keratocystic odontogenic tumor?: A large systematic review and meta-analysis.在牙源性角化囊性瘤的治疗后,哪种手术治疗的复发率最低?一项大型系统评价和荟萃分析。
J Craniomaxillofac Surg. 2017 Jan;45(1):131-144. doi: 10.1016/j.jcms.2016.10.013. Epub 2016 Oct 31.
3
Topical 5-Fluorouracil is a Novel Targeted Therapy for the Keratocystic Odontogenic Tumor.局部应用5-氟尿嘧啶是牙源性角化囊性瘤的一种新型靶向治疗方法。
J Oral Maxillofac Surg. 2017 Mar;75(3):514-524. doi: 10.1016/j.joms.2016.09.039. Epub 2016 Sep 30.
4
Current Role of Carnoy's Solution in Treating Keratocystic Odontogenic Tumors.卡诺氏液在治疗牙源性角化囊性瘤中的当前作用
J Oral Maxillofac Surg. 2016 Feb;74(2):278-82. doi: 10.1016/j.joms.2015.07.018. Epub 2015 Jul 28.
5
Keratocystic Odontogenic Tumor (KCOT/OKC)-Clinical Guidelines for Resection.牙源性角化囊性瘤(KCOT/OKC)切除临床指南
J Maxillofac Oral Surg. 2015 Sep;14(3):558-64. doi: 10.1007/s12663-014-0732-7. Epub 2015 Jan 4.
6
Underestimated PTCH1 mutation rate in sporadic keratocystic odontogenic tumors.散发性牙源性角化囊性瘤中PTCH1突变率被低估
Oral Oncol. 2015 Jan;51(1):40-5. doi: 10.1016/j.oraloncology.2014.09.016. Epub 2014 Nov 18.
7
Smoothened gene alterations in keratocystic odontogenic tumors.角化囊性牙源性肿瘤中的平滑肌瘤基因改变。
Head Face Med. 2014 Sep 5;10:36. doi: 10.1186/1746-160X-10-36.
8
A systematic review of the recurrence rate for keratocystic odontogenic tumour in relation to treatment modalities.系统回顾牙源性角化囊性瘤的复发率与治疗方式的关系。
Int J Oral Maxillofac Surg. 2012 Jun;41(6):756-67. doi: 10.1016/j.ijom.2012.02.008. Epub 2012 Mar 23.
9
Endoscopic resection and topical 5-Fluorouracil as an alternative treatment to craniofacial resection for the management of primary intestinal-type sinonasal adenocarcinoma.内镜下切除联合局部应用5-氟尿嘧啶作为原发性肠型鼻窦腺癌治疗中颅面切除术的替代治疗方法。
Minim Invasive Surg. 2010;2010:750253. doi: 10.1155/2010/750253. Epub 2011 Feb 16.
10
Interventions for the treatment of keratocystic odontogenic tumours (KCOT, odontogenic keratocysts (OKC)).治疗牙源性角化囊性瘤(KCOT,牙源性角化囊肿(OKC))的干预措施。
Cochrane Database Syst Rev. 2010 Sep 8(9):CD008464. doi: 10.1002/14651858.CD008464.pub2.

局部应用5-氟尿嘧啶治疗牙源性角化囊肿

Topical 5-fluorouracil application in management of odontogenic keratocysts.

作者信息

Akhter Lone Parveen, Ahmed Wani Nisar, Ahmed Janbaz Zubair, Bibi Mehnaz, Kour Amit

机构信息

Indira Gandhi Government Dental College Amphalla Jammu Affiliated to University of Jammu, India.

Consultant Pediatric Radio Diagnosis GB Pant Hospital Srinagar Kashmir Affiliated to University of Kashmir, India.

出版信息

J Oral Biol Craniofac Res. 2020 Oct-Dec;10(4):404-406. doi: 10.1016/j.jobcr.2020.07.008. Epub 2020 Jul 22.

DOI:10.1016/j.jobcr.2020.07.008
PMID:32775182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7394907/
Abstract

AIM & OBJECTIVES: The aim of this study was to evaluate the efficacy of topical application of 5-fluorouracil (5-FU) after peripheral ostectomy, and compare it with other treatment modalities in the management of odontogenic keratocyst (OKC).

MATERIALS &METHODS: This prospective study was conducted in the OMFS department for last seven years, wherein twenty seven patients of OKC were included and randomly allocated to the three treatment groups. Nine were treated by enucleation followed by application of modified carnoy solution (CS), eleven by peripheral ostectomy followed by application of 5-FU and eleven by segmental resection (SR). Follow-up ranged from 2 to 4 years to assess bone healing and record any recurrence of lesion.

RESULTS

Amongst twenty seven patients, eighteen were males and nine females, age range 20-66 years. The most common location of OKC was posterior mandible. Complications included nerve injury, swelling, infection, and recurrence (66.6% after modified CS). Functional and aesthetic compromise was seen in resection patients whereas application of 5-FU had minimal nerve injuries, infection, swelling, no recurrence with no compromise in aesthetics and function.

CONCLUSION

Management of OKC by 5-FU is a novel surgical method having less morbidity, minimal recurrence, low cost, no functional or cosmetic deformity.

摘要

目的

本研究旨在评估外周骨切除术联合局部应用5-氟尿嘧啶(5-FU)的疗效,并将其与牙源性角化囊肿(OKC)的其他治疗方式进行比较。

材料与方法

这项前瞻性研究在口腔颌面外科进行了7年,纳入了27例OKC患者,并随机分为三个治疗组。9例患者采用刮除术加改良卡诺伊溶液(CS)治疗,11例采用外周骨切除术加5-FU治疗,11例采用节段性切除术(SR)治疗。随访时间为2至4年,以评估骨愈合情况并记录病变的任何复发情况。

结果

27例患者中,18例为男性,9例为女性,年龄范围为20至66岁。OKC最常见的部位是下颌骨后部。并发症包括神经损伤、肿胀、感染和复发(改良CS治疗后复发率为66.6%)。节段性切除术患者出现了功能和美观方面的问题,而应用5-FU的患者神经损伤、感染、肿胀最少,无复发,且美观和功能不受影响。

结论

5-FU治疗OKC是一种新的手术方法,具有发病率低、复发率低、成本低、无功能或美容畸形等优点。